Parimal Chowdhury, Departments of Physiology and Biophysics, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, Arkansas 72205, United States

Kodetthoor B Udupa, Departments of Physiology and Biophysics and Geriatrics, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, Arkansas 72205, United States

Kodetthoor B Udupa, Medical Service, Central Arkansas Veterans Healthcare System, Little Rick, Arkansas 72205,

United States

Correspondence to: Parimal Chowdhury, PhD, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, Arkansas 72205, United States. pchowdhury@uams.edu

Telephone: +1-501-6865443  Fax: +1-501-6868167

Received: 2006-07-29           Accepted: 2006-08-11

Abstract

Cell proliferation is an important process in life for growth of normal and cancer cells. The signal transduction pathways activated during this process are strictly regulated. This editorial focuses on the role of nicotine, a mitogen, in the induction of signaling pathways resulting in proliferation of  pancreatic tumor cells and compares these events with those in normal acinar cells isolated from the rat pancreas. The data shows striking similarities between these two cellular systems. In addition, the editorial reviews very recent literature of the contribution of MAPK signaling in cell lines associated with human diseases. A prospective cellular model of nicotine induced activation of MAPK cascade is presented.

© 2006 The WJG Press. All rights reserved.

Key words: Cell Proliferation; Nicotine; AR42J cells; Pancreatic acinar cells; ERK activation

Chowdhury P, Udupa KB. Nicotine as a mitogenic stimulus for pancreatic acinar cell proliferation. World J Gastroenterol 2006; 12(46): 7428-7432

 http://www.wjgnet.com/1007-9327/12/7428.asp

INTRODUCTION

Cell proliferation is a strictly regulated event. The rate of cell division depends upon instructions by which the cell responds to mitogenic or other stimuli in order to enter the cell cycle substantiated by cyclin dependent kinases (CDKs) which are activated by cyclins. In a normal resting cell the intracellular signaling proteins and genes, activated by extracellular growth factors, are quiescent. However, when stimulated by growth factors, the cells undergo proliferation. In cancer cells, intracellular signaling proteins and oncogenes activated by the growth factors remain constitutively active^[1]. In response to growth factors or other mitogenic stimuli, three major types of signal transduction pathways are activated in a cell: mitogen activated protein kinase (MAPK) pathways, protein kinase C (PKC) pathways and JAK/STAT pathways. Activation of each of these pathways requires a phosphorylation step that regulates cell proliferation and differentiation^[1].

Understanding of the complex molecular mechanisms involved in the regulation of cell proliferation in normal and cancer cells will provide us with tools to intervene in the regulation and control of the cell cycle in the presence of a mitogen. Qualitatively speaking, the biochemistry of growth of tumor and normal cells appear similar^[2]. The fundamental difference most probably lies in a relaxation of regulation of cell growth^[3,4]. Here we will discuss the role of nicotine in cell proliferation in reference to AR42J cells (a rat pancreatic tumor cell line) and look further into extended observations from our recent findings using primary cells derived from the normal rat pancreas when exposed to nicotine in culture.

Nicotine is a major component of cigarette smoke and is a known risk factor for the development of numerous diseases^[5-9]. The role of nicotine/smoking as a risk factor for the induction of pancreatic inflammation and pancreatic cancer has been reported recently^[10,11]. The mechanism by which nicotine induces such pathologies is as yet unknown. Understanding of the proliferative potential of nicotine in primary and tumor cells of the pancreas will allow us to develop measures that will ultimately lead to intervention, prevention and treatment.

AR42J CELLS: CHARACTERISTICS AND ASSOCIATION WITH MAP KINASES

AR42J is a stable, rat pancreatic tumor cell line derived from the hyperplastic pancreatic nodules of male rats following the administration of azaserine^[12]. Because of their unique properties of stability, secretory capacity, and growth potential^[13], these cells have been extensively used as an in vitro model for studying exocytotic secretory processes and activation of signal transduction pathways^[14-16]. In response to regulatory peptides, AR42J cells can be stimulated to secrete enzymes and induce proliferation^[13,17,18]. 

MAPK enzymes play critical roles in the regulation of cell proliferation, differentiation, and apoptosis, and are comprised of a ubiquitous family of tyrosine/threonine kinases that include the extracellular signal-regulated kinases (ERK1/2), c-jun NH₂-terminal kinases (JNK1/2), and p38 MAPK. Cytokines and mitogens trigger signaling cascades that lead to the activation of MAPK, as reported in studies with different cell lines^[19-24].

Activation of ERK has been primarily implicated in cell proliferation and survival, whereas activation of JNK and p38 are associated with growth arrest and apoptosis^[25-27]. Induction of MAPK’s leads to the phosphorylation and activation of a variety of proteins, including a number of transcription factors involved in regulating the expression of genes controlling cellular proliferation^[28-30]. ERK1/2 is found in most tumors and is involved in gastric carcinogenesis^[31]. Differential activation of MAPK by cholecystokinin (CCK) and bombesin has been reported in AR42J cells^[17].

ACTIVATION OF SIGNALING PATHWAYS BY NICOTINE

Nicotine is known to activate several MAPK signaling pathways in a variety of tissue and cell types^[32-37]. It also behaves like a growth factor promoting survival of human lung cancer cells^[38]. Studies show that nicotine can increase the cell numbers of certain cancer cell lines^[39-41]. This suggests that nicotine exposure can lead to the disruption of the dynamic balance between cell death and proliferation, which is required for normal functioning of cells. 

In pulmonary neuroendocrine cells, nicotine binds to nicotinic receptors, resulting in the phosphorylation of ERK and stimulation of DNA synthesis^[32,42]. Furthermore, nicotine induces Ca²⁺ influx and stimulates the Ras/ERK cascade that promotes cell survival in neuronal cells^[43]. Thus, ERK1/2 is one of the possible signaling pathways involved in nicotine-induced cell proliferation. Studies by Bose et al^[44] on the mitogenic effect of nicotine on AR42J cells show that nicotine activates ERK1/2 in AR42J cells and induces proliferation without affecting basal and stimulated enzyme secretion. These data suggest that MAPK signaling by nicotine in AR42J cells is independent of the secretory response.

ACTIVATION OF SIGNALING PATHWAYS BY NICOTINE IN PRIMARY CELLS: EFFECTS ON PROLIFERATION

Primary cells are normally derived from intact rat pancreas. The functional status of the primary acinar cells exposed to nicotine under basal and stimulated conditions has been reported^[45,46]. However, the ability of nicotine to activate MAPK signaling pathways and subsequent proliferation has not yet been reported. It has been shown that p42 MAPK is fully activated at 5 min by cholecystokinin (CCK) in freshly isolated pancreatic acini, and JNK is activated maximally at 30 min and remains significantly elevated at 60 min^[47,48]. Unpublished studies from our laboratory show that exposure of primary cells to nicotine in short term culture activates ERK1/2 MAPK with very little or no effect on JNK and p38 MAPK. The results on primary cells from this study and the studies cited above thus demonstrate that some parallelism in the time-dependent activation of ERK by CCK and nicotine exists, although these two secretagogues are completely different from one another in terms of their biological actions on the pancreas^[15,48,49]. Further, cell proliferation studies conducted and monitored with three independent methods (MTT assay, BrdU assay and flow cytometry) confirmed the proliferative ability of primary cells in the presence of nicotine. This response is reversed in the presence of the ERK1/2 inhibitor UO126, suggesting that the proliferation induced by nicotine in primary cells is MAPK-dependent. Activation of these signals and application of their inhibitors in the presence of nicotine had no effect on the stimulated enzyme secretion by these cells (unpublished observations). The proliferation of primary cells by nicotine thus appears to be independent of the stimulus-secretion coupling response of amylase secretion.

ACTIVATION OF MAPK SIGNALING PATHWAYS IN CELL LINES DERIVED FROM HUMAN DISEASES

MAPKs are known to exert several complex functions, such as regulation of cellular growth, proliferation, and differentiation^[29,50,51]. It has also been shown that activation of ERK1/2 MAPK is associated with cell proliferative signals whereas activations of c-jun NH₂-terminal kinases 1/2 (JNK1/2) and p38 MAPKs are associated with stress-response signaling^[52,53]. Zhao et al^[54] have shown that in the human T lymphoma cell line Molt-4, ERK and p-38 mitogen activated protein kinase (MAPK) signaling are induced in response to hepatitis C virus E2 envelope protein resulting in alterations in cell behavior. In human squamous cell carcinomas (SCC) of the larynx, the potential derangement of MAPK pathways which showed decreased activity of ERK1/2 p44/42 reflecting alterations in tumor suppressing activity, has been reported^[55]. Application of low power laser irradiation (LPLI) has been shown to promote cellular proliferation of human dental pulp derived fibroblast-like cells (dental pulp cells) inducing the activation of ERK 1/2 with no induction pf p38 MAPK or c-Jun N-terminal kinase (JNK) phosphorylation^[56]. Hepatocyte growth factor (HGF) also enhanced proliferation and differentiation of dental pulp cells by partial activation of the ERK/MAPK pathway^[57].

Recently Li et al have shown that anti-apoptotic human phosphatidylethanolamine-binding protein (hPEBP4) silencing, promotes tumor necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways^[58]. Mutant huntingtin, a protein derived from Huntington disease (HD) affects signaling at upstream points activating ERK and JNK, suggesting that pharmacological intervention of MAPK pathways may be an appropriate approach to HD therapy^[59]. ERK 1 expression has been shown to be an early marker of cervical carcinogenesis^[60]. In human glomerulopathies, activation of ERK pathways has been correlated with cell proliferation, histologic lesions, and renal dysfunction^[61]. In human neutrophils, Rac/Cdc-dependent activation of MAPK/ERK is a critical event in the immediate phagocytic response of PMNs to microbial challenge^[62]. IL-1 beta stimulated human airway smooth muscle cells demonstrate activated p38 MAPK, JNK kinase and p42/p44 ERK suggesting their role in the inflammatory process in asthma^[63]. In the human myeloma cell line SKO-007, activation of ERK in the Ras/MAPK signaling pathway has been shown to play important differences in their responsiveness to IFN-alpha^[64]. Signaling through SAPK/MAK pathways is shown to be a typical feature of chronic synovitis in rheumatoid arthritis, but not in degenerative joint disease. SAPK/MAPK signaling is found at distinct sites in the synovial tissue and is induced by proinflammatory cytokines^[65].

CONCLUSIONS

The possible signaling pathways leading to cell proliferation by nicotine are shown in Figure 1 below. The schematic shows that nicotine enters the cell either by diffusion or via a calcium regulated pathway as demonstrated earlier^[66].  Entry of nicotine induces the activation of Ras-Raf-MEK-ERK pathways inducing phosphorylation of the MAP kinase cascade. Substrates of ERK in the cytosol include tyrosine kinase receptors among others. Substrates of ERK in the nucleus include transcription factors such as ELK-1 and others. The endpoint of ERK phosphorylation leads to the assembly of transcription factors which stimulate the production of proteins causing cells to proliferate and grow.

Figure 1 The possible organisation of the Ras-Raf-MEK-ERK pathway by nicotine.

The parallelism observed in nicotine-induced cell proliferation studies conducted in a mutant pancreatic cell line and freshly isolated pancreatic acinar cells suggest the possibility that this stable mutant line can be used for extensive evaluation of signal transduction pathways mediating oncogenesis. The data gathered from these studies can be extended to assess the mechanisms of development of pancreatic diseases induced in animal models exposed to chronic/sub-chronic exposure to nicotine or cigarette smoking.

References

1    Molecular Biology of the Cell. Cell Proliferation. Alberts B, Bray D, Johnson A, Lewis J, Raff M, Roberts K, Walter P, eds. New York & London: Garland Publishing INC, 1998 

2    Weber G. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res 1983; 43: 3466-3492  PubMed

3    Fingert HJ, Campisi J, Pardee AB.  Molecular Biology and Biochemistry of Cancer. In Gynecologic Oncology. R Knap, R Berkowitz, eds. New York: Macmillan, 1991: 30

4    Gibbs JB, Oliff A, Kohl NE. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 1994; 77: 175-178  PubMed

5    National Center for Chronic Disease Prevention and Health Promotion. Health Consequences of Smoking: a Report of the Surgeon General. Washington D.C: National Institutes of Health, 2004

6    Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology 2003; 8: 17-21  PubMed

7    Slattery ML, Edwards S, Curtin K, Schaffer D, Neuhausen S. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 882-889  PubMed

8    Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 2001; 10: 875-882  PubMed

9    Lowenfels AB, Maisonneuve P, Lankisch PG. Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am 1999; 28: 673-685, x  PubMed

10   Malfertheiner P, Schutte K. Smoking-a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol 2006; 101: 160-162  PubMed

11   Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B, Batra SK. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 2006; 101: 148-159  PubMed

12   Longnecker DS, Lilja HS, French J, Kuhlmann E, Noll W Transplantation of azaserine-induced carcinomas of pancreas in rats. Cancer Lett 1979; 7: 197-202  PubMed

13   Christophe J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am J Physiol 1994; 266: G963-G971  PubMed

14   Duan RD, Williams JA. Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Am J Physiol 1994; 267: G401-G408  PubMed

15   Duan RD, Zheng CF, Guan KL, Williams JA. Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini. Am J Physiol 1995; 268: G1060-G1065  PubMed

16   Williams JA. Intracellular signaling mechanisms activated by cholecystokinin-regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells. Annu Rev Physiol 2001; 63: 77-97  PubMed

17   Kiehne K, Herzig KH, Folsch UR. Differential activation of p42ERK2 and p125FAK by cholecystokinin and bombesin in the secretion and proliferation of the pancreatic amphicrine cell line AR42J. Pancreatology 2002; 2: 46-53  PubMed

18   Thommesen L, Norsett K, Sandvik AK, Hofsli E, Laegreid A. Regulation of inducible cAMP early repressor expression by gastrin and cholecystokinin in the pancreatic cell line AR42J. J Biol Chem 2000; 275: 4244-4250  PubMed

19   Bose C, Bhuvaneswaran C, Udupa KB. Altered mitogen-activated protein kinase signal transduction in human skin fibroblasts during in vitro aging: differential expression of low-density lipoprotein receptor. J Gerontol A Biol Sci Med Sci 2004; 59: 126-135  PubMed

20   Clarke N, Arenzana N, Hai T, Minden A, Prywes R. Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Mol Cell Biol 1998; 18: 1065-1073  PubMed

21   Kumar A, Middleton A, Chambers TC, Mehta KD. Differential roles of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1beta- and tumor necrosis factor-alpha-induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 1998; 273: 15742-15748  PubMed

22   McDermott EP, O’Neill LA. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1. J Biol Chem 2002; 277: 7808-7815  PubMed

23   Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994; 266: 1719-1723  PubMed

24   Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 1994; 269: 26396-26401  PubMed

25   Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol 1999; 71: 479-500  PubMed

26   Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal 2000; 12: 1-13  PubMed

27   Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW, Plevin R. Stress-activated protein kinases: activation, regulation and function. Cell Signal 1997; 9: 403-410  PubMed

28   Bose C, Bhuvaneswaran C, Udupa KB. Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase and its relation to LDL receptor and MAPK. Mech Ageing Dev 2005; 126: 740-751   PubMed

29   Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268: 14553-14556  PubMed

30   Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995; 269: 403-407  PubMed

31   Shin VY, Wu WK, Ye YN, So WH, Koo MW, Liu ES, Luo JC, Cho CH. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis 2004; 25: 2487-2495  PubMed

32   Heusch WL, Maneckjee R. Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis 1998; 19: 551-556  PubMed

33   Nakayama H, Numakawa T, Ikeuchi T, Hatanaka H. Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. J Neurochem 2001; 79: 489-498  PubMed

34   Nakayama H, Numakawa T, Ikeuchi T. Nicotine-induced phosphorylation of Akt through epidermal growth factor receptor and Src in PC12h cells. J Neurochem 2002; 83: 1372-1379  PubMed

35   Schuller HM, Porter B, Riechert A, Walker K, Schmoyer R. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer 2004; 45: 11-18  PubMed

36   Tang K, Wu H, Mahata SK, O’Connor DT. A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. Mol Pharmacol 1998; 54: 59-69  PubMed

37   Wang J, Chen YB, Zhu XN, Chen RZ. Activation of p42/44 mitogen-activated protein kinase pathway in long-term potentiation induced by nicotine in hippocampal CA1 region in rats. Acta Pharmacol Sin 2001; 22: 685-690  PubMed

38   Jin Z, Gao F, Flagg T, Deng X. Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J Biol Chem 2004; 279: 23837-23844  PubMed

39   Cattaneo MG, Codignola A, Vicentini LM, Clementi F, Sher E. Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res 1993; 53: 5566-5568   PubMed

40   Quik M, Chan J, Patrick J. alpha-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res 1994; 655: 161-167   PubMed

41   Schuller HM. Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways. Neurotoxicology 1994; 15: 877-886   PubMed

42   Aguayo SM. Pulmonary neuroendocrine cells in tobacco-related lung disorders. Anat Rec 1993; 236: 122-127; discussion 127-128  PubMed

43   Itano N, Atsumi F, Sawai T, Yamada Y, Miyaishi O, Senga T, Hamaguchi M, Kimata K. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA 2002; 99: 3609-3614  PubMed

44   Bose C, Zhang H, Udupa KB, Chowdhury P. Activation of p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J: effects on proliferation and secretion. Am J Physiol Gastrointest Liver Physiol 2005; 289: G926-G934   PubMed

45   Chowdhury P, Hosotani R, Chang L, Rayford PL. Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats. Pancreas 1990; 5: 222-229  PubMed

46   Chowdhury P, Hosotani R, Rayford PL. Inhibition of CCK or carbachol-stimulated amylase release by nicotine. Life Sci 1989; 45: 2163-2168  PubMed

47   Dabrowski A, Grady T, Logsdon CD, Williams JA. Jun kinases are rapidly activated by cholecystokinin in rat pancreas both in vitro and in vivo. J Biol Chem 1996; 271: 5686-5690  PubMed

48   Duan RD, Williams JA. Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Am J Physiol 1994; 267: G401-G408   PubMed

49   Doi R, Chowdhury P, Rayford PL. Agonist-regulated alteration of the affinity of pancreatic muscarinic cholinergic receptors. J Biol Chem 1993; 268: 22436-22443  PubMed

50   Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-185  PubMed

51   Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-180  PubMed

52   Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME Opposing effects of ERK and JNK-p38 MAP kinase on apoptosis. Science 1995; 270: 1326-1331  PubMed

53   Harper SJ, LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 2001; 13: 299-310  PubMed

54   Zhao LJ, Zhang XL, Zhao P, Cao J, Cao MM, Zhu SY, Liu HQ, Qi ZT. Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. J Leukoc Biol 2006; 80: 424-432  PubMed

55   Garavello W, Nicolini G, Aguzzi A, Maggioni D, Leone BE, Vigano P, Gaini RM, Tredici G. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx. Oncol Rep 2006; 16: 479-484  PubMed

56   Miyata H, Genma T, Ohshima M, Yamaguchi Y, Hayashi M, Takeichi O, Ogiso B, Otsuka K. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation of cultured human dental pulp cells by low-power gallium-aluminium-arsenic laser irradiation. Int Endod J 2006; 39: 238-244  PubMed

57   Ye L, Peng L, Tan H, Zhou X. HGF enhanced proliferation and differentiation of dental pulp cells. J Endod 2006; 32: 736-741  PubMed

58   Li P, Wang X, Li N, Kong H, Guo Z, Liu S, Cao X. Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways. Int J Mol Med 2006; 18: 505-510  PubMed

59   Apostol BL, Illes K, Pallos J, Bodai L, Wu J, Strand A, Schweitzer ES, Olson JM, Kazantsev A, Marsh JL, Thompson LM. Mutant huntingtin alters MAPK signaling pathways in PC 12 and striatal cells: ERK 1/2 protects against mutant huntingtin-associated toxicity. Human Mol Gen 2006; 15: 273-285 

60   Branca M, Ciotti M, Santini D, Bonito LD, Benedetto A, Giorgi C, Paba P, Favalli C, Costa S, Agarossi A, Alderisio M, Syrjanen K. Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer. Am J Clin Pathol 2004; 122: 902-911  PubMed

62   Zhong B, Jiang K, Gilvary DL, Epling-Burnette PK, Ritchey C, Liu J, Jackson RJ, Hong-Geller E, Wei S. Human neutrophils utilize a Rac/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization toward ingested microbial pathogens. Blood 2003; 101: 3240-3248   PubMed

63   Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells. Respir Med 2003; 97: 811-817  PubMed

64   Song L, Li Y, Shen B. Protein kinase ERK contributes to differential responsiveness of human myeloma cell lines to IFNalpha. Cancer Cell Int 2002; 2: 9  PubMed

65   Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000; 43: 2501-2512   PubMed

66   Chowdhury P, MacLeod S, Udupa KB, Rayford PL. Pathophysiological effects of nicotine on the pancreas: an update. Exp Biol Med (Maywood) 2002; 227: 445-454   PubMed

S- Editor Liu Y L- Editor Lalor PF E- Editor Bai SH